Axonics, Inc.

DB:0I3 Stock Report

Market Cap: €3.4b

Axonics Management

Management criteria checks 2/4

Axonics' CEO is Ray Cohen, appointed in Oct 2013, has a tenure of 11.08 years. total yearly compensation is $7.37M, comprised of 10.9% salary and 89.1% bonuses, including company stock and options. directly owns 0.57% of the company’s shares, worth €19.62M. The average tenure of the management team and the board of directors is 7 years and 5.6 years respectively.

Key information

Ray Cohen

Chief executive officer

US$7.4m

Total compensation

CEO salary percentage10.9%
CEO tenure11.1yrs
CEO ownership0.6%
Management average tenure7yrs
Board average tenure5.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Ray Cohen's remuneration changed compared to Axonics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$6m

Jun 30 2024n/an/a

-US$2m

Mar 31 2024n/an/a

-US$16m

Dec 31 2023US$7mUS$800k

-US$6m

Sep 30 2023n/an/a

-US$12m

Jun 30 2023n/an/a

-US$32m

Mar 31 2023n/an/a

-US$46m

Dec 31 2022US$5mUS$750k

-US$60m

Sep 30 2022n/an/a

-US$76m

Jun 30 2022n/an/a

-US$77m

Mar 31 2022n/an/a

-US$80m

Dec 31 2021US$6mUS$625k

-US$80m

Sep 30 2021n/an/a

-US$76m

Jun 30 2021n/an/a

-US$68m

Mar 31 2021n/an/a

-US$63m

Dec 31 2020US$1mUS$527k

-US$55m

Sep 30 2020n/an/a

-US$66m

Jun 30 2020n/an/a

-US$82m

Mar 31 2020n/an/a

-US$81m

Dec 31 2019US$6mUS$500k

-US$80m

Sep 30 2019n/an/a

-US$67m

Jun 30 2019n/an/a

-US$49m

Mar 31 2019n/an/a

-US$39m

Dec 31 2018US$1mUS$430k

-US$32m

Sep 30 2018n/an/a

-US$28m

Jun 30 2018n/an/a

-US$25m

Mar 31 2018n/an/a

-US$20m

Dec 31 2017US$605kUS$430k

-US$18m

Compensation vs Market: Ray's total compensation ($USD7.37M) is above average for companies of similar size in the German market ($USD2.09M).

Compensation vs Earnings: Ray's compensation has increased whilst the company is unprofitable.

CEO

Ray Cohen (65 yo)

11.1yrs

Tenure

US$7,369,375

Compensation

Mr. Raymond W. Cohen, also known as Ray, is Independent Director of Kestra Medical Technologies, Inc. from July 2024. Mr. Cohen is Venture Advisor of Andera Partners. He focuses on Life Sciences.He works...

Leadership Team

NamePositionTenureCompensationOwnership
Raymond Cohen
CEO & Director11.1yrsUS$7.37m0.57%
€ 19.6m
Kari Keese
Chief Financial Officer1.1yrsUS$3.76m0.079%
€ 2.7m
Rinda Sama
Chief Operating Officer6.3yrsUS$3.04m0.17%
€ 5.7m
John Woock
Executive VP6.4yrsUS$3.26m0.15%
€ 5.2m
Alfred Ford
Chief Commercial Officer7yrsUS$2.94m0.085%
€ 2.9m
Guangqiang Jiang
Chief Technology Officer11.1yrsno datano data
Neil Bhalodkar
Vice President of Investor Relationsno datano datano data
Aaron Pettit
General Counsel & Chief Compliance Officerno datano datano data
Michael Williamson
Senior VPno datano datano data
Karen Noblett
Chief Medical Officer7.1yrsUS$651.40k0.067%
€ 2.3m
Prabodh Mathur
Chief Product Development Officer10.5yrsno datano data

7.0yrs

Average Tenure

52yo

Average Age

Experienced Management: 0I3's management team is seasoned and experienced (7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Raymond Cohen
CEO & Director11.1yrsUS$7.37m0.57%
€ 19.6m
Michael Carrel
Independent Chairman5.8yrsUS$250.00k0.035%
€ 1.2m
Nancy Snyderman
Independent Director5.6yrsUS$222.50k0.039%
€ 1.3m
David Demski
Independent Director3.8yrsUS$210.00k0.019%
€ 639.4k
Robert McNamara
Independent Director6yrsUS$227.50k0.029%
€ 996.0k
Jane Kiernan
Independent Director5.6yrsUS$225.00k0.039%
€ 1.3m
Esteban Lopez
Independent Director3.3yrsUS$215.00k0.013%
€ 442.2k

5.6yrs

Average Tenure

65yo

Average Age

Experienced Board: 0I3's board of directors are considered experienced (5.6 years average tenure).